“This is Prostate Cancer Awareness Month, but it feels more like Prostate Cancer Propaganda Month,” Joel Keehn, senior editor at Consumer Reports Health.Org observed in a recent phone conversation.
Consumer Reports Health.Org has posted an excellent piece on why deciding to have a PSA test to detect early-stage prostate cancer is not a slam-dunk decision. We just don’t have any medical evidence that the test saves lives—or even lengthens life by one day. But we do have evidence that current treatments can lead to life-changing side-effects. See the post here.
Meanwhile those who profit from prostate cancer treatments are taking full advantage of “Prostate Cancer Awareness Month.” On the post, Keehn notes that “during this year’s U.S. Tennis Open the former tennis star John McEnroe has been promoting prostate-cancer screening for men as young as age 40, citing new recommendations from the American Urological Association.” (No surprise, the urologists who administer the tests and treatments endorse them.) “But during his appearances on CNN’s Larry King Live and the Early Show on CBS, there’s been no mention that most organizations, including the American Cancer Society and the United States Preventive Services Task Force” no longer recommend routine testing.They “emphasize that the evidence for the test is sketchy,” Keehen writes. “As a result, those organizations say that men should discuss the pros and cons of the test with their doctor.
“Nor was it mentioned that McEnroe was being paid for his efforts by the pharmaceutical giant GlaxoSmithKline,” Keehn adds, “which just happens to make dutasteride (Avodart), a prostate medication that GSK hopes may be used as a prostate-cancer prevention drug. And the Web site he promotes during those appearances, no surprise, is also funded by the drug maker.”For further information on treatments for prostate cancer—including “watchful waiting,” see these HealthBeat posts here and here.